SpiN-Tec MCTI UFMG

Chimeric recombinant Covid-19 vaccine · Federal University of Minas Gerais

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SpiN-Tec MCTI UFMG, covering 2025-09-15 to 2025-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG [Phase 1, Phase 2]